Broadcom: The Dip Won't Last Long, Great Opportunity To Own The AI Leader

Broadcom reported record Q2 FY26 revenue up 47.9% YoY, driven by explosive AI semiconductor demand. Its AI silicon business now represents 49% of consolidated revenue and, alongside an elevated backlog, should support continued top-line growth through FY26. Management expects operating leverage to sustain strong margins, even as high R&D continues to pressure profitability.

Analysis

AVGO is becoming the cleanest public proxy for hyperscaler AI capex, but the more important signal is second-order: custom silicon is still taking share of the AI budget from merchant architectures without slowing overall spend. That is constructive for TSM, AMAT, LRCX, and KLA on the manufacturing/tooling side, while keeping NVDA and MRVL in a healthy but more competitive lane as buyers diversify training and inference architectures.

The risk is that the market continues to value AVGO as a diversified compounder while the business is increasingly concentrated in a handful of cloud customers. Over the next 1-3 months, the key catalyst is not the print itself but whether hyperscaler capex guides stay elevated; if they soften, AVGO can de-rate quickly even with a full backlog. Over 6-18 months, the issue is whether R&D intensity and custom-design complexity start to cap operating leverage as the revenue mix shifts further toward AI.

Contrarian view: consensus may be underpricing concentration risk and overpricing backlog durability. The bull case remains intact, but at some point the stock will trade on the sustainability of AI order flow rather than the headline growth rate. If AVGO starts to move as a pure AI beta, the better expression may be to own the upstream picks-and-shovels with less customer concentration and use AVGO as the higher-volatility vehicle only on pullbacks.

Key Decisions for Investors

• Long AVGO on any 3-5% post-print pullback over the next 1-2 weeks; target a 10-15% move over 1-3 months if FY26 AI demand stays intact. Falsify if management signals backlog normalization or AI growth deceleration.
• Pair trade: long AVGO / short QCOM for the next 1-3 months. This isolates AI semiconductor exposure versus handset-driven cyclicality; cover if QCOM surprises on handset recovery or AVGO customer concentration worsens.
• Prefer upstream beneficiaries TSM and AMAT over AVGO for 6-18 months if the market starts discounting concentration risk in AVGO. Those names monetize AI capex with less single-name customer risk.
• Use AVGO call spreads rather than outright stock for a 6-9 month expression if implied vol remains elevated; this captures continued AI backlog upside while limiting multiple-compression risk.
• Set a watch item for hyperscaler capex commentary in MSFT, AMZN, GOOGL, and META next quarter; any capex pause would be the earliest high-signal warning that AVGO's growth rate can roll over faster than the market expects.